Robust neutralizing antibodies to SARS-CoV-2 infection persist for months
As the number of daily COVID-19 cases continues to mount worldwide, the nature of the humoral immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remains uncertain. Wajnberg et al. used a cohort of more than 30,000 infected individuals with mild to moderate COVID-19 sympt...
Saved in:
| Published in | Science (American Association for the Advancement of Science) Vol. 370; no. 6521; pp. 1227 - 1230 |
|---|---|
| Main Authors | , , , , , , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
United States
The American Association for the Advancement of Science
04.12.2020
American Association for the Advancement of Science |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | As the number of daily COVID-19 cases continues to mount worldwide, the nature of the humoral immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remains uncertain. Wajnberg
et al.
used a cohort of more than 30,000 infected individuals with mild to moderate COVID-19 symptoms to determine the robustness and longevity of the anti–SARS-CoV-2 antibody response. They found that neutralizing antibody titers against the SARS-CoV-2 spike protein persisted for at least 5 months after infection. Although continued monitoring of this cohort will be needed to confirm the longevity and potency of this response, these preliminary results suggest that the chance of reinfection may be lower than is currently feared.
Science
, this issue p.
1227
Antibodies generated after mild to moderate SARS-CoV-2 infection are neutralizing and relatively stable for at least 5 months.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global pandemic with millions infected and more than 1 million fatalities. Questions regarding the robustness, functionality, and longevity of the antibody response to the virus remain unanswered. Here, on the basis of a dataset of 30,082 individuals screened at Mount Sinai Health System in New York City, we report that the vast majority of infected individuals with mild-to-moderate COVID-19 experience robust immunoglobulin G antibody responses against the viral spike protein. We also show that titers are relatively stable for at least a period of about 5 months and that anti-spike binding titers significantly correlate with neutralization of authentic SARS-CoV-2. Our data suggest that more than 90% of seroconverters make detectable neutralizing antibody responses. These titers remain relatively stable for several months after infection. |
|---|---|
| AbstractList | SARS-CoV-2 antibodies persistAs the number of daily COVID-19 cases continues to mount worldwide, the nature of the humoral immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remains uncertain. Wajnberg et al. used a cohort of more than 30,000 infected individuals with mild to moderate COVID-19 symptoms to determine the robustness and longevity of the anti–SARS-CoV-2 antibody response. They found that neutralizing antibody titers against the SARS-CoV-2 spike protein persisted for at least 5 months after infection. Although continued monitoring of this cohort will be needed to confirm the longevity and potency of this response, these preliminary results suggest that the chance of reinfection may be lower than is currently feared.Science, this issue p. 1227Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global pandemic with millions infected and more than 1 million fatalities. Questions regarding the robustness, functionality, and longevity of the antibody response to the virus remain unanswered. Here, on the basis of a dataset of 30,082 individuals screened at Mount Sinai Health System in New York City, we report that the vast majority of infected individuals with mild-to-moderate COVID-19 experience robust immunoglobulin G antibody responses against the viral spike protein. We also show that titers are relatively stable for at least a period of about 5 months and that anti-spike binding titers significantly correlate with neutralization of authentic SARS-CoV-2. Our data suggest that more than 90% of seroconverters make detectable neutralizing antibody responses. These titers remain relatively stable for several months after infection. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global pandemic with millions infected and more than 1 million fatalities. Questions regarding the robustness, functionality, and longevity of the antibody response to the virus remain unanswered. Here, on the basis of a dataset of 30,082 individuals screened at Mount Sinai Health System in New York City, we report that the vast majority of infected individuals with mild-to-moderate COVID-19 experience robust immunoglobulin G antibody responses against the viral spike protein. We also show that titers are relatively stable for at least a period of about 5 months and that anti-spike binding titers significantly correlate with neutralization of authentic SARS-CoV-2. Our data suggest that more than 90% of seroconverters make detectable neutralizing antibody responses. These titers remain relatively stable for several months after infection.Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global pandemic with millions infected and more than 1 million fatalities. Questions regarding the robustness, functionality, and longevity of the antibody response to the virus remain unanswered. Here, on the basis of a dataset of 30,082 individuals screened at Mount Sinai Health System in New York City, we report that the vast majority of infected individuals with mild-to-moderate COVID-19 experience robust immunoglobulin G antibody responses against the viral spike protein. We also show that titers are relatively stable for at least a period of about 5 months and that anti-spike binding titers significantly correlate with neutralization of authentic SARS-CoV-2. Our data suggest that more than 90% of seroconverters make detectable neutralizing antibody responses. These titers remain relatively stable for several months after infection. As the number of daily COVID-19 cases continues to mount worldwide, the nature of the humoral immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remains uncertain. Wajnberg et al. used a cohort of more than 30,000 infected individuals with mild to moderate COVID-19 symptoms to determine the robustness and longevity of the anti–SARS-CoV-2 antibody response. They found that neutralizing antibody titers against the SARS-CoV-2 spike protein persisted for at least 5 months after infection. Although continued monitoring of this cohort will be needed to confirm the longevity and potency of this response, these preliminary results suggest that the chance of reinfection may be lower than is currently feared. Science , this issue p. 1227 Antibodies generated after mild to moderate SARS-CoV-2 infection are neutralizing and relatively stable for at least 5 months. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global pandemic with millions infected and more than 1 million fatalities. Questions regarding the robustness, functionality, and longevity of the antibody response to the virus remain unanswered. Here, on the basis of a dataset of 30,082 individuals screened at Mount Sinai Health System in New York City, we report that the vast majority of infected individuals with mild-to-moderate COVID-19 experience robust immunoglobulin G antibody responses against the viral spike protein. We also show that titers are relatively stable for at least a period of about 5 months and that anti-spike binding titers significantly correlate with neutralization of authentic SARS-CoV-2. Our data suggest that more than 90% of seroconverters make detectable neutralizing antibody responses. These titers remain relatively stable for several months after infection. As the number of daily COVID-19 cases continues to mount worldwide, the nature of the humoral immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remains uncertain. Wajnberg et al. used a cohort of more than 30,000 infected individuals with mild to moderate COVID-19 symptoms to determine the robustness and longevity of the anti–SARS-CoV-2 antibody response. They found that neutralizing antibody titers against the SARS-CoV-2 spike protein persisted for at least 5 months after infection. Although continued monitoring of this cohort will be needed to confirm the longevity and potency of this response, these preliminary results suggest that the chance of reinfection may be lower than is currently feared. Science , this issue p. 1227 Antibodies generated after mild to moderate SARS-CoV-2 infection are neutralizing and relatively stable for at least 5 months. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global pandemic with millions infected and more than 1 million fatalities. Questions regarding the robustness, functionality, and longevity of the antibody response to the virus remain unanswered. Here, on the basis of a dataset of 30,082 individuals screened at Mount Sinai Health System in New York City, we report that the vast majority of infected individuals with mild-to-moderate COVID-19 experience robust immunoglobulin G antibody responses against the viral spike protein. We also show that titers are relatively stable for at least a period of about 5 months and that anti-spike binding titers significantly correlate with neutralization of authentic SARS-CoV-2. Our data suggest that more than 90% of seroconverters make detectable neutralizing antibody responses. These titers remain relatively stable for several months after infection. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global pandemic with millions infected and more than 1 million fatalities. Questions regarding the robustness, functionality, and longevity of the antibody response to the virus remain unanswered. Here, on the basis of a dataset of 30,082 individuals screened at Mount Sinai Health System in New York City, we report that the vast majority of infected individuals with mild-to-moderate COVID-19 experience robust immunoglobulin G antibody responses against the viral spike protein. We also show that titers are relatively stable for at least a period of about 5 months and that anti-spike binding titers significantly correlate with neutralization of authentic SARS-CoV-2. Our data suggest that more than 90% of seroconverters make detectable neutralizing antibody responses. These titers remain relatively stable for several months after infection. |
| Author | Meade, Philip Krammer, Florian Amanat, Fatima Cordon-Cardo, Carlos Mansour, Mayce Wajnberg, Ania Bailey, Mark J. Stone, Kimberly Muellers, Kimberly Aberg, Judith Mendu, Damodara Rao Reich, David L. Altman, Deena R. Strohmeier, Shirin Firpo, Adolfo Simon, Viviana McMahon, Meagan Stadlbauer, Daniel |
| Author_xml | – sequence: 1 givenname: Ania orcidid: 0000-0001-5063-7016 surname: Wajnberg fullname: Wajnberg, Ania organization: Department of General Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA – sequence: 2 givenname: Fatima orcidid: 0000-0002-8029-8227 surname: Amanat fullname: Amanat, Fatima organization: Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA – sequence: 3 givenname: Adolfo surname: Firpo fullname: Firpo, Adolfo organization: Clinical Microbiology Laboratory, Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA – sequence: 4 givenname: Deena R. orcidid: 0000-0003-1948-3834 surname: Altman fullname: Altman, Deena R. organization: Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA – sequence: 5 givenname: Mark J. surname: Bailey fullname: Bailey, Mark J. organization: Department of General Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA – sequence: 6 givenname: Mayce orcidid: 0000-0003-2628-9474 surname: Mansour fullname: Mansour, Mayce organization: Department of General Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA – sequence: 7 givenname: Meagan orcidid: 0000-0002-7450-6624 surname: McMahon fullname: McMahon, Meagan organization: Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA – sequence: 8 givenname: Philip orcidid: 0000-0002-6754-7209 surname: Meade fullname: Meade, Philip organization: Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA – sequence: 9 givenname: Damodara Rao surname: Mendu fullname: Mendu, Damodara Rao organization: Clinical Microbiology Laboratory, Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA – sequence: 10 givenname: Kimberly orcidid: 0000-0001-6217-272X surname: Muellers fullname: Muellers, Kimberly organization: Department of General Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA – sequence: 11 givenname: Daniel orcidid: 0000-0001-6792-7650 surname: Stadlbauer fullname: Stadlbauer, Daniel organization: Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA – sequence: 12 givenname: Kimberly surname: Stone fullname: Stone, Kimberly organization: Department of General Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA – sequence: 13 givenname: Shirin surname: Strohmeier fullname: Strohmeier, Shirin organization: Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA – sequence: 14 givenname: Viviana orcidid: 0000-0002-6416-5096 surname: Simon fullname: Simon, Viviana organization: Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA – sequence: 15 givenname: Judith orcidid: 0000-0001-8162-0284 surname: Aberg fullname: Aberg, Judith organization: Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA – sequence: 16 givenname: David L. orcidid: 0000-0003-0095-515X surname: Reich fullname: Reich, David L. organization: Department of Anesthesiology, Perioperative and Pain Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA – sequence: 17 givenname: Florian orcidid: 0000-0003-4121-776X surname: Krammer fullname: Krammer, Florian organization: Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA – sequence: 18 givenname: Carlos orcidid: 0000-0003-0858-5624 surname: Cordon-Cardo fullname: Cordon-Cardo, Carlos organization: Clinical Microbiology Laboratory, Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33115920$$D View this record in MEDLINE/PubMed |
| BookMark | eNp1kc1LHTEUxYNY6tN27U4G3HQzmo_JJLMR5GFVEAradhuSzI1G5iXPJCPYv755-Cqt0NVd3N85nHvPPtoNMQBChwSfEEL702w9BAsn2oxCULmDFgQPvB0oZrtogTHrW4kF30P7OT9iXHcD-4j2GCOEV2iBrm-jmXNpAswl6cn_8uG-0aF4E0cPuSmxuTu_vWuX8WdLGx8c2OJjaNaQsq86F1OziqE85E_og9NThs_beYB-fL34vrxqb75dXi_Pb1rLCS-to5waAaLnrrPWdQYPWlvmHJE942M3iqHvByOxpU4aLICz0RBKRy7xAFKyA3T26ruezQpGC2ETXK2TX-n0oqL26t9N8A_qPj4rIUl9iKgGX7YGKT7NkIta-WxhmnSAOGdFO85lhyUhFT1-hz7GOYV6XqV60RPMBlypo78TvUX58-UKnL4CNsWcE7g3hGC16VFte1TbHquCv1NYX_Tm8_UkP_1X9xvvc6VC |
| CitedBy_id | crossref_primary_10_1016_j_cell_2021_06_005 crossref_primary_10_3390_ijerph182413173 crossref_primary_10_3390_vaccines11020461 crossref_primary_10_1038_s43856_022_00084_w crossref_primary_10_1016_j_jinf_2021_05_026 crossref_primary_10_3390_tropicalmed6020041 crossref_primary_10_3390_vaccines10071160 crossref_primary_10_1007_s12275_022_1598_x crossref_primary_10_1002_JPER_22_0152 crossref_primary_10_1016_j_bios_2022_114054 crossref_primary_10_1371_journal_pone_0307936 crossref_primary_10_1128_mSphere_00224_21 crossref_primary_10_1136_bmj_m4288 crossref_primary_10_37349_ei_2025_1003180 crossref_primary_10_1136_bmjopen_2020_047216 crossref_primary_10_2139_ssrn_3919680 crossref_primary_10_7189_jogh_12_95955 crossref_primary_10_1093_infdis_jiab314 crossref_primary_10_2139_ssrn_4131160 crossref_primary_10_15789_1563_0625_PTF_2905 crossref_primary_10_1038_s41598_022_20747_x crossref_primary_10_3390_v13030516 crossref_primary_10_1177_10998004231161632 crossref_primary_10_1093_nsr_nwab006 crossref_primary_10_3389_fimmu_2022_914167 crossref_primary_10_1038_s41467_022_28898_1 crossref_primary_10_1371_journal_ppat_1009453 crossref_primary_10_1016_j_jinf_2023_08_010 crossref_primary_10_1038_s41421_022_00496_x crossref_primary_10_3390_vaccines13030310 crossref_primary_10_3390_v14020370 crossref_primary_10_3390_life11080805 crossref_primary_10_1007_s12032_021_01540_8 crossref_primary_10_1080_22221751_2021_1898291 crossref_primary_10_3390_diagnostics11030483 crossref_primary_10_1007_s00284_022_02800_0 crossref_primary_10_3389_fneur_2022_843081 crossref_primary_10_1186_s40779_021_00342_3 crossref_primary_10_3390_cancers13051035 crossref_primary_10_1177_03946320221133697 crossref_primary_10_1038_s41590_022_01248_5 crossref_primary_10_1016_j_jvacx_2021_100126 crossref_primary_10_1128_mbio_03580_21 crossref_primary_10_1002_ange_202110819 crossref_primary_10_1016_j_ijid_2021_02_076 crossref_primary_10_1515_mr_2024_0013 crossref_primary_10_3389_fpubh_2023_1164326 crossref_primary_10_1039_D1LC00627D crossref_primary_10_3389_fmed_2021_631769 crossref_primary_10_1007_s10096_021_04178_6 crossref_primary_10_3390_vaccines10081186 crossref_primary_10_1177_10406387211057859 crossref_primary_10_1172_jci_insight_150909 crossref_primary_10_1002_jmv_29067 crossref_primary_10_1128_mBio_01002_21 crossref_primary_10_1128_spectrum_03165_22 crossref_primary_10_1136_postgradmedj_2020_139555 crossref_primary_10_1186_s13756_023_01324_x crossref_primary_10_1038_s41598_023_43263_y crossref_primary_10_1126_sciimmunol_abl4509 crossref_primary_10_3390_pathogens11030286 crossref_primary_10_3390_cancers13184621 crossref_primary_10_1016_j_cmi_2021_08_023 crossref_primary_10_1111_tme_12868 crossref_primary_10_3389_fimmu_2021_722027 crossref_primary_10_3389_fmicb_2021_770727 crossref_primary_10_15789_2220_7619_COT_1809 crossref_primary_10_1016_j_xcrm_2022_100600 crossref_primary_10_1007_s12070_022_03202_1 crossref_primary_10_1111_sji_13345 crossref_primary_10_1016_j_ebiom_2022_103972 crossref_primary_10_14336_AD_2021_0217 crossref_primary_10_1371_journal_ppat_1009668 crossref_primary_10_3390_ijerph19010407 crossref_primary_10_1126_scitranslmed_abl8124 crossref_primary_10_3390_biology11091274 crossref_primary_10_1089_vim_2021_0121 crossref_primary_10_1093_ecco_jcc_jjad065 crossref_primary_10_1080_22221751_2021_1913973 crossref_primary_10_1038_s41541_021_00331_6 crossref_primary_10_1080_22221751_2021_1913974 crossref_primary_10_3389_fimmu_2021_723585 crossref_primary_10_1016_j_celrep_2022_110336 crossref_primary_10_1002_iid3_583 crossref_primary_10_1371_journal_pone_0262911 crossref_primary_10_1016_j_medj_2021_01_005 crossref_primary_10_1038_s41467_021_23333_3 crossref_primary_10_1007_s00508_021_01985_x crossref_primary_10_1038_s41467_021_23938_8 crossref_primary_10_2169_internalmedicine_8019_21 crossref_primary_10_1002_iid3_595 crossref_primary_10_1038_s41587_021_00878_8 crossref_primary_10_1016_j_jim_2024_113712 crossref_primary_10_1136_jnnp_2022_329395 crossref_primary_10_3389_fimmu_2023_1159326 crossref_primary_10_3389_fped_2021_638502 crossref_primary_10_1016_j_jcv_2021_104797 crossref_primary_10_3389_fimmu_2023_1242536 crossref_primary_10_3390_vaccines9030223 crossref_primary_10_1093_jalm_jfac034 crossref_primary_10_1016_j_clnesp_2024_05_015 crossref_primary_10_1007_s10096_021_04232_3 crossref_primary_10_2139_ssrn_3943152 crossref_primary_10_1016_j_jcvp_2021_100041 crossref_primary_10_1016_j_lanwpc_2022_100660 crossref_primary_10_1093_infdis_jiab333 crossref_primary_10_1016_j_jcvp_2021_100044 crossref_primary_10_1371_journal_pone_0280584 crossref_primary_10_1016_j_heliyon_2023_e15679 crossref_primary_10_3389_fimmu_2021_633184 crossref_primary_10_3390_vaccines11050935 crossref_primary_10_3390_jcm10194606 crossref_primary_10_1038_s41392_021_00861_4 crossref_primary_10_1093_cid_ciac054 crossref_primary_10_1093_infdis_jiab140 crossref_primary_10_3390_vaccines9101082 crossref_primary_10_5812_semj_121681 crossref_primary_10_1016_j_ijid_2021_10_010 crossref_primary_10_3390_biology10030208 crossref_primary_10_1016_j_lanepe_2021_100115 crossref_primary_10_1007_s11427_020_1859_y crossref_primary_10_4049_jimmunol_2100155 crossref_primary_10_2139_ssrn_3879083 crossref_primary_10_1016_j_puhe_2022_01_011 crossref_primary_10_1111_ctr_14825 crossref_primary_10_3390_v13010040 crossref_primary_10_1186_s12985_024_02573_x crossref_primary_10_4049_immunohorizons_2100022 crossref_primary_10_1128_mbio_02250_23 crossref_primary_10_1093_infdis_jiac005 crossref_primary_10_4274_tji_galenos_2022_58070 crossref_primary_10_3389_fimmu_2023_1241038 crossref_primary_10_1007_s40472_023_00414_4 crossref_primary_10_1371_journal_pone_0267102 crossref_primary_10_1038_s41541_022_00502_z crossref_primary_10_1016_j_jcvp_2022_100130 crossref_primary_10_1016_j_jmb_2022_167800 crossref_primary_10_1093_infdis_jiab127 crossref_primary_10_1016_S0140_6736_20_32656_8 crossref_primary_10_1093_infdis_jiab125 crossref_primary_10_3390_biomedicines9101342 crossref_primary_10_1126_scitranslmed_abf8654 crossref_primary_10_3390_microorganisms9071389 crossref_primary_10_1038_s41586_021_03207_w crossref_primary_10_1002_jmv_27270 crossref_primary_10_1093_clinchem_hvab069 crossref_primary_10_1038_s43856_021_00012_4 crossref_primary_10_1093_ije_dyab217 crossref_primary_10_1080_03007995_2021_1914943 crossref_primary_10_1128_spectrum_02507_21 crossref_primary_10_1360_nso_20220009 crossref_primary_10_1038_s41598_021_83969_5 crossref_primary_10_1128_jvi_01664_22 crossref_primary_10_1016_j_bsheal_2021_09_002 crossref_primary_10_1002_jmv_27281 crossref_primary_10_1016_j_ijid_2021_03_031 crossref_primary_10_1093_clinchem_hvab051 crossref_primary_10_1016_j_jaci_2022_01_005 crossref_primary_10_1111_joim_13304 crossref_primary_10_1515_cclm_2020_1736 crossref_primary_10_1016_j_physa_2021_126717 crossref_primary_10_1088_1478_3975_ac7e9e crossref_primary_10_1016_j_jinf_2022_02_001 crossref_primary_10_1089_vim_2021_0191 crossref_primary_10_1128_spectrum_01333_24 crossref_primary_10_1542_peds_2021_052173 crossref_primary_10_1016_j_clim_2021_108814 crossref_primary_10_1080_14737159_2021_1882852 crossref_primary_10_1097_INF_0000000000003574 crossref_primary_10_1371_journal_pgph_0003893 crossref_primary_10_17942_sted_892713 crossref_primary_10_1038_s41598_024_75658_w crossref_primary_10_1016_S0140_6736_20_32318_7 crossref_primary_10_1007_s10875_022_01256_y crossref_primary_10_7883_yoken_JJID_2023_255 crossref_primary_10_1038_s41392_021_00523_5 crossref_primary_10_1016_j_cmi_2021_06_040 crossref_primary_10_1093_infdis_jiac017 crossref_primary_10_1002_anie_202015362 crossref_primary_10_1016_j_immuni_2022_01_001 crossref_primary_10_1161_JAHA_120_019506 crossref_primary_10_3389_fimmu_2023_1203803 crossref_primary_10_1093_infdis_jiab161 crossref_primary_10_3390_vaccines11121787 crossref_primary_10_1007_s10900_022_01142_z crossref_primary_10_1038_s41598_022_17605_1 crossref_primary_10_3390_microorganisms9030556 crossref_primary_10_3389_fimmu_2023_1244556 crossref_primary_10_1097_TP_0000000000003983 crossref_primary_10_1002_rmv_2231 crossref_primary_10_1016_j_ebiom_2021_103259 crossref_primary_10_1016_S2665_9913_21_00393_3 crossref_primary_10_1093_infdis_jiad116 crossref_primary_10_3390_vaccines12060564 crossref_primary_10_2139_ssrn_3933997 crossref_primary_10_1016_j_jviromet_2021_114222 crossref_primary_10_1038_s41467_023_42717_1 crossref_primary_10_1080_20477724_2022_2029301 crossref_primary_10_1016_j_chom_2021_06_009 crossref_primary_10_3390_jcm10040779 crossref_primary_10_1093_cid_ciab004 crossref_primary_10_1097_j_pbj_0000000000000171 crossref_primary_10_1186_s12967_021_02938_8 crossref_primary_10_3390_ijerph18041488 crossref_primary_10_3389_fimmu_2022_1000006 crossref_primary_10_3390_pathogens13060514 crossref_primary_10_1038_s41467_021_22958_8 crossref_primary_10_3389_fimmu_2021_804808 crossref_primary_10_3390_ijms24065352 crossref_primary_10_1016_j_clim_2021_108730 crossref_primary_10_1136_bmjopen_2021_052752 crossref_primary_10_1038_s41423_023_01122_w crossref_primary_10_1177_15353702221084966 crossref_primary_10_1016_j_isci_2023_106562 crossref_primary_10_3390_vaccines9020147 crossref_primary_10_30629_0023_2149_2020_98_8_593_599 crossref_primary_10_12688_wellcomeopenres_19414_1 crossref_primary_10_1002_jmv_27784 crossref_primary_10_1016_j_microc_2024_111126 crossref_primary_10_1016_j_clinmicnews_2021_02_001 crossref_primary_10_1038_s42003_021_02835_2 crossref_primary_10_1111_trf_16261 crossref_primary_10_12688_wellcomeopenres_19414_2 crossref_primary_10_1002_cti2_1261 crossref_primary_10_3390_v14061222 crossref_primary_10_1111_1348_0421_12962 crossref_primary_10_2139_ssrn_3902468 crossref_primary_10_1681_ASN_2020111618 crossref_primary_10_3389_fmicb_2021_803031 crossref_primary_10_2217_fmb_2022_0121 crossref_primary_10_1093_ckj_sfac031 crossref_primary_10_1186_s12879_022_07173_0 crossref_primary_10_1016_j_virol_2021_02_007 crossref_primary_10_1016_j_preghy_2025_101205 crossref_primary_10_1038_s41586_021_04117_7 crossref_primary_10_1093_cid_ciac310 crossref_primary_10_1007_s00508_020_01795_7 crossref_primary_10_1186_s12879_021_05927_w crossref_primary_10_1038_s41577_021_00522_1 crossref_primary_10_1590_0037_8682_0106_2022 crossref_primary_10_1128_Spectrum_00327_21 crossref_primary_10_1186_s12879_022_07314_5 crossref_primary_10_1210_clinem_dgab055 crossref_primary_10_3201_eid2703_204543 crossref_primary_10_3389_fimmu_2021_743422 crossref_primary_10_3389_fimmu_2021_790469 crossref_primary_10_1080_21645515_2021_1886560 crossref_primary_10_1016_j_xpro_2022_101835 crossref_primary_10_3399_BJGPO_2021_0038 crossref_primary_10_1186_s12879_023_08298_6 crossref_primary_10_1016_j_ebiom_2022_104208 crossref_primary_10_1371_journal_pone_0279956 crossref_primary_10_3390_vaccines10060937 crossref_primary_10_1007_s11845_021_02716_x crossref_primary_10_1016_j_bbrc_2021_05_073 crossref_primary_10_1007_s15010_021_01598_6 crossref_primary_10_1097_TXD_0000000000001397 crossref_primary_10_1016_j_jaci_2022_11_010 crossref_primary_10_1111_joim_13387 crossref_primary_10_1002_path_5642 crossref_primary_10_1016_S0140_6736_21_00238_5 crossref_primary_10_3390_ijerph18105085 crossref_primary_10_3390_vaccines10081210 crossref_primary_10_1038_s41467_021_24285_4 crossref_primary_10_3390_vaccines10010012 crossref_primary_10_1038_s41564_021_00974_0 crossref_primary_10_1016_S1473_3099_20_30884_7 crossref_primary_10_3390_v14091916 crossref_primary_10_1152_ajpheart_00325_2021 crossref_primary_10_1097_FTD_0000000000000945 crossref_primary_10_3390_v13112270 crossref_primary_10_1128_msphere_00883_21 crossref_primary_10_1371_journal_ppat_1010092 crossref_primary_10_1097_MD_0000000000030609 crossref_primary_10_1080_21645515_2022_2047582 crossref_primary_10_3390_v13102003 crossref_primary_10_1128_JCM_01138_21 crossref_primary_10_33920_med_08_2212_02 crossref_primary_10_1016_j_lanepe_2021_100027 crossref_primary_10_3390_biomedicines9101303 crossref_primary_10_1097_IPC_0000000000001043 crossref_primary_10_3390_vaccines9091017 crossref_primary_10_1002_eji_202149758 crossref_primary_10_1016_j_tim_2021_03_016 crossref_primary_10_3389_fimmu_2021_709759 crossref_primary_10_1371_journal_pmed_1003868 crossref_primary_10_1371_journal_pone_0264667 crossref_primary_10_3390_life11060565 crossref_primary_10_1038_s41586_021_03647_4 crossref_primary_10_1128_Spectrum_00224_21 crossref_primary_10_4103_jfmpc_jfmpc_272_23 crossref_primary_10_1007_s11606_021_07057_0 crossref_primary_10_1016_j_jvacx_2023_100371 crossref_primary_10_3389_fcimb_2023_1239700 crossref_primary_10_1038_s41419_022_05190_0 crossref_primary_10_1089_vim_2022_0117 crossref_primary_10_1016_j_ijid_2020_12_075 crossref_primary_10_1038_s41598_023_29198_4 crossref_primary_10_1016_j_chom_2021_04_015 crossref_primary_10_1002_ehf2_13798 crossref_primary_10_1371_journal_pmed_1003877 crossref_primary_10_1038_s41598_022_12869_z crossref_primary_10_1128_spectrum_02468_22 crossref_primary_10_1016_j_jsps_2021_09_006 crossref_primary_10_1002_mef2_70004 crossref_primary_10_3389_fimmu_2021_701411 crossref_primary_10_1111_ppe_12812 crossref_primary_10_1002_eji_202149535 crossref_primary_10_1038_s41467_021_22351_5 crossref_primary_10_5858_arpa_2021_0423_SA crossref_primary_10_3390_pathogens10060751 crossref_primary_10_3201_eid2705_204365 crossref_primary_10_1016_j_xcrm_2021_100486 crossref_primary_10_1056_NEJMoa2034545 crossref_primary_10_1016_j_xcrm_2022_100523 crossref_primary_10_3390_ijerph192113798 crossref_primary_10_1038_s41598_021_96129_6 crossref_primary_10_1371_journal_pone_0276829 crossref_primary_10_1038_s41591_020_01202_8 crossref_primary_10_3390_v16040551 crossref_primary_10_1016_j_ijid_2020_12_017 crossref_primary_10_1016_j_ymthe_2023_03_018 crossref_primary_10_4103_mgmj_mgmj_34_21 crossref_primary_10_1002_eji_202149302 crossref_primary_10_3390_v13071225 crossref_primary_10_3390_vaccines9050524 crossref_primary_10_3390_vaccines10030455 crossref_primary_10_1007_s40472_021_00322_5 crossref_primary_10_1016_j_ijid_2021_09_021 crossref_primary_10_1371_journal_pmed_1003656 crossref_primary_10_1016_j_xcrm_2021_100253 crossref_primary_10_1093_cid_ciaa1846 crossref_primary_10_3390_v14122665 crossref_primary_10_5812_jjm_142026 crossref_primary_10_3390_cells10061508 crossref_primary_10_1001_jamanetworkopen_2022_1313 crossref_primary_10_1016_j_celrep_2021_110114 crossref_primary_10_1136_bmjopen_2021_048874 crossref_primary_10_1042_BST20220415 crossref_primary_10_1038_s42003_021_01813_y crossref_primary_10_3390_v15020504 crossref_primary_10_3390_v13061064 crossref_primary_10_1038_s41408_021_00546_9 crossref_primary_10_1155_2021_9822706 crossref_primary_10_1002_oby_23208 crossref_primary_10_1007_s00430_022_00740_x crossref_primary_10_1093_ecco_jcc_jjac029 crossref_primary_10_1126_science_abe9728 crossref_primary_10_1021_acsami_4c20770 crossref_primary_10_1172_JCI144930 crossref_primary_10_1016_j_idnow_2022_01_004 crossref_primary_10_1038_s41467_021_26479_2 crossref_primary_10_3389_fimmu_2023_1183727 crossref_primary_10_1016_j_medj_2021_02_001 crossref_primary_10_1128_spectrum_00211_22 crossref_primary_10_1038_s41467_021_24230_5 crossref_primary_10_1016_j_ijid_2021_09_002 crossref_primary_10_1126_sciadv_adq4545 crossref_primary_10_1159_000529913 crossref_primary_10_26633_RPSP_2021_66 crossref_primary_10_1093_cid_ciab607 crossref_primary_10_2807_1560_7917_ES_2021_26_27_2100568 crossref_primary_10_1016_j_ekir_2021_03_902 crossref_primary_10_1371_journal_pone_0260038 crossref_primary_10_47316_cajmhe_2021_2_1_05 crossref_primary_10_1681_ASN_2021020188 crossref_primary_10_1007_s00277_021_04662_1 crossref_primary_10_1002_jmv_26878 crossref_primary_10_3390_microorganisms10010085 crossref_primary_10_1128_mSphere_00275_21 crossref_primary_10_1038_s41467_021_24123_7 crossref_primary_10_1177_03000605211069279 crossref_primary_10_3390_v12121357 crossref_primary_10_1186_s12916_022_02570_3 crossref_primary_10_1016_j_ajog_2021_09_037 crossref_primary_10_1080_22221751_2021_1971569 crossref_primary_10_1016_j_jcv_2021_104988 crossref_primary_10_3889_oamjms_2022_9957 crossref_primary_10_1055_a_1246_0550 crossref_primary_10_1128_mSphere_00170_21 crossref_primary_10_35772_ghm_2022_01070 crossref_primary_10_1016_j_xcrm_2021_100296 crossref_primary_10_1038_s41577_021_00657_1 crossref_primary_10_1038_s41598_024_51968_x crossref_primary_10_1126_science_abf4063 crossref_primary_10_1126_sciimmunol_abf3698 crossref_primary_10_1038_s41598_021_93175_y crossref_primary_10_1007_s40615_021_01193_3 crossref_primary_10_47993_gmb_v45i1_382 crossref_primary_10_1002_jmv_27751 crossref_primary_10_3389_fimmu_2021_659041 crossref_primary_10_1016_j_cmi_2021_09_005 crossref_primary_10_1186_s13049_021_00969_0 crossref_primary_10_1016_j_virol_2024_110113 crossref_primary_10_1016_j_immuni_2022_05_004 crossref_primary_10_1186_s12916_021_02090_6 crossref_primary_10_1038_s41577_020_00493_9 crossref_primary_10_3390_vaccines10020242 crossref_primary_10_1016_j_lanepe_2021_100098 crossref_primary_10_2139_ssrn_3751788 crossref_primary_10_3346_jkms_2021_36_e294 crossref_primary_10_1038_s41467_021_26137_7 crossref_primary_10_1016_j_isci_2023_106506 crossref_primary_10_1021_acs_jcim_3c00813 crossref_primary_10_1039_D2LC00960A crossref_primary_10_1016_j_lana_2021_100123 crossref_primary_10_1128_msphere_00193_22 crossref_primary_10_1007_s00430_022_00753_6 crossref_primary_10_31631_2073_3046_2023_22_6_90_98 crossref_primary_10_3390_v14030526 crossref_primary_10_1371_journal_pone_0272690 crossref_primary_10_3389_fonc_2021_734963 crossref_primary_10_3389_fpls_2023_1325162 crossref_primary_10_1039_D2SD00073C crossref_primary_10_1128_JVI_00404_21 crossref_primary_10_1111_trf_16714 crossref_primary_10_1084_jem_20210359 crossref_primary_10_1016_j_annepidem_2021_08_013 crossref_primary_10_1126_sciimmunol_abg5669 crossref_primary_10_1128_JCM_00989_21 crossref_primary_10_1136_medethics_2020_107117 crossref_primary_10_1038_s41591_021_01285_x crossref_primary_10_1016_j_lansea_2024_100470 crossref_primary_10_1136_jitc_2021_002550 crossref_primary_10_1080_14760584_2021_1977630 crossref_primary_10_1111_all_15502 crossref_primary_10_1128_mBio_01229_21 crossref_primary_10_1038_s41577_021_00550_x crossref_primary_10_3389_fcimb_2022_988604 crossref_primary_10_1053_j_gastro_2020_12_042 crossref_primary_10_1016_j_ejim_2021_05_010 crossref_primary_10_1371_journal_ppat_1010569 crossref_primary_10_3389_fimmu_2021_654165 crossref_primary_10_1016_j_talanta_2024_126606 crossref_primary_10_1186_s12916_021_02149_4 crossref_primary_10_1016_j_clinbiochem_2021_08_006 crossref_primary_10_1093_jalm_jfab018 crossref_primary_10_1001_jamanetworkopen_2021_10782 crossref_primary_10_1002_eji_202149277 crossref_primary_10_1371_journal_pone_0280276 crossref_primary_10_1371_journal_pone_0281365 crossref_primary_10_3389_fimmu_2021_636768 crossref_primary_10_1016_j_mayocpiqo_2022_10_001 crossref_primary_10_1038_s41598_022_06629_2 crossref_primary_10_1371_journal_pone_0252818 crossref_primary_10_1016_j_eclinm_2020_100651 crossref_primary_10_1093_jalm_jfab027 crossref_primary_10_1038_s41392_021_00559_7 crossref_primary_10_1186_s12916_022_02240_4 crossref_primary_10_1093_infdis_jiab411 crossref_primary_10_3390_jcm10215111 crossref_primary_10_1111_apa_16031 crossref_primary_10_1124_pharmrev_120_000285 crossref_primary_10_1016_j_ebiom_2021_103561 crossref_primary_10_3928_19382359_20210421_02 crossref_primary_10_3389_fimmu_2023_1055457 crossref_primary_10_1093_infdis_jiab222 crossref_primary_10_1093_oxfimm_iqab018 crossref_primary_10_1016_j_biopha_2021_112282 crossref_primary_10_1016_j_kint_2021_12_009 crossref_primary_10_1016_j_intimp_2021_107893 crossref_primary_10_1016_j_isci_2024_109210 crossref_primary_10_1080_08830185_2022_2079642 crossref_primary_10_1016_j_isci_2024_110441 crossref_primary_10_1016_j_jim_2022_113243 crossref_primary_10_1016_j_clinbiochem_2021_09_008 crossref_primary_10_1002_anie_202110819 crossref_primary_10_1093_oxfimm_iqab003 crossref_primary_10_21518_2079_701X_2022_16_4_51_65 crossref_primary_10_3389_fimmu_2022_915338 crossref_primary_10_3389_fphys_2021_652198 crossref_primary_10_1016_j_ebiom_2024_105354 crossref_primary_10_3390_diagnostics12081781 crossref_primary_10_1093_oxfimm_iqab006 crossref_primary_10_1038_s41467_021_24979_9 crossref_primary_10_1371_journal_ppat_1009772 crossref_primary_10_1161_CIRCRESAHA_122_319954 crossref_primary_10_2144_fsoa_2022_0048 crossref_primary_10_4049_jimmunol_2200297 crossref_primary_10_1016_j_heliyon_2021_e08444 crossref_primary_10_3389_fmolb_2023_1157651 crossref_primary_10_1016_j_xcrm_2021_100420 crossref_primary_10_1016_j_ejim_2021_05_028 crossref_primary_10_3389_fimmu_2022_862522 crossref_primary_10_1038_s41598_021_04279_4 crossref_primary_10_1016_j_bpa_2020_12_003 crossref_primary_10_3389_fimmu_2022_836495 crossref_primary_10_3138_cjgim_v15i5_453 crossref_primary_10_2139_ssrn_4191112 crossref_primary_10_21931_RB_2022_07_01_36 crossref_primary_10_1016_j_hsr_2023_100127 crossref_primary_10_3389_fimmu_2021_681586 crossref_primary_10_3389_fimmu_2022_830710 crossref_primary_10_3390_ijerph192215257 crossref_primary_10_1186_s12879_024_09615_3 crossref_primary_10_1016_j_cell_2021_01_050 crossref_primary_10_1038_s41467_022_32573_w crossref_primary_10_1128_Spectrum_00391_21 crossref_primary_10_1136_annrheumdis_2021_220736 crossref_primary_10_3390_diagnostics13172722 crossref_primary_10_1371_journal_ppat_1010741 crossref_primary_10_3389_fmed_2021_642723 crossref_primary_10_1172_jci_insight_155889 crossref_primary_10_3390_covid1010006 crossref_primary_10_1038_s41467_021_26602_3 crossref_primary_10_1002_jmv_27135 crossref_primary_10_3389_fimmu_2021_742631 crossref_primary_10_1080_22221751_2022_2046446 crossref_primary_10_1038_s41467_021_21503_x crossref_primary_10_1126_sciimmunol_abg6916 crossref_primary_10_1038_s41598_022_15791_6 crossref_primary_10_17650_1726_9784_2021_20_4_10_17 crossref_primary_10_46234_ccdcw2023_075 crossref_primary_10_1016_S2213_2600_21_00407_0 crossref_primary_10_1016_j_eimc_2021_01_013 crossref_primary_10_1136_bmjopen_2022_063760 crossref_primary_10_3390_vaccines11091398 crossref_primary_10_1007_s10439_024_03478_0 crossref_primary_10_1021_acsnano_1c03972 crossref_primary_10_1016_j_eclinm_2021_100975 crossref_primary_10_1186_s12865_024_00596_1 crossref_primary_10_1038_s41598_021_93148_1 crossref_primary_10_1136_bmjopen_2022_061345 crossref_primary_10_1016_S1473_3099_20_30943_9 crossref_primary_10_1038_s41590_021_00902_8 crossref_primary_10_3389_fmed_2021_653630 crossref_primary_10_52455_sbpr_01_202103011 crossref_primary_10_1016_S0140_6736_23_00810_3 crossref_primary_10_1016_j_vaccine_2022_08_058 crossref_primary_10_3389_fimmu_2023_1131985 crossref_primary_10_1021_acssensors_1c00612 crossref_primary_10_3389_fimmu_2025_1494624 crossref_primary_10_4049_jimmunol_2100036 crossref_primary_10_1038_s41392_021_00797_9 crossref_primary_10_1371_journal_pone_0272818 crossref_primary_10_1093_infdis_jiab008 crossref_primary_10_1093_ofid_ofab626 crossref_primary_10_1097_QCO_0000000000000724 crossref_primary_10_2217_nnm_2023_0122 crossref_primary_10_1007_s10067_021_05801_9 crossref_primary_10_3390_v15040917 crossref_primary_10_1016_j_tmaid_2020_101949 crossref_primary_10_1002_hsr2_572 crossref_primary_10_1128_mbio_01784_22 crossref_primary_10_1371_journal_ppat_1009723 crossref_primary_10_1002_smtd_202100058 crossref_primary_10_1016_j_ijbiomac_2024_135201 crossref_primary_10_3390_diagnostics11010124 crossref_primary_10_1097_CM9_0000000000001892 crossref_primary_10_1080_21645515_2022_2051412 crossref_primary_10_1177_00220345211020270 crossref_primary_10_1038_s43856_022_00119_2 crossref_primary_10_3389_fphar_2023_1125305 crossref_primary_10_1111_all_14840 crossref_primary_10_22207_JPAM_17_1_56 crossref_primary_10_1071_MA21010 crossref_primary_10_1016_j_ijmmb_2022_07_009 crossref_primary_10_1016_S0140_6736_21_00675_9 crossref_primary_10_1111_imr_13115 crossref_primary_10_1186_s12879_022_07102_1 crossref_primary_10_1002_eji_202049058 crossref_primary_10_1016_j_eimce_2021_01_009 crossref_primary_10_4103_mjdrdypu_mjdrdypu_819_22 crossref_primary_10_1186_s13045_021_01046_w crossref_primary_10_1556_650_2023_32709 crossref_primary_10_3390_vaccines9101168 crossref_primary_10_1007_s11739_021_02860_3 crossref_primary_10_46234_ccdcw2021_044 crossref_primary_10_1016_j_transci_2021_103063 crossref_primary_10_1002_14651858_CD014946 crossref_primary_10_1002_cti2_1339 crossref_primary_10_24075_brsmu_2024_023 crossref_primary_10_1016_j_jcvp_2022_100089 crossref_primary_10_3389_fimmu_2021_682850 crossref_primary_10_1093_infdis_jiac167 crossref_primary_10_1128_spectrum_02706_21 crossref_primary_10_1016_j_kint_2021_04_018 crossref_primary_10_7326_M21_0256 crossref_primary_10_3389_fimmu_2022_993754 crossref_primary_10_1016_j_cll_2021_10_004 crossref_primary_10_1016_j_cll_2021_10_003 crossref_primary_10_1016_j_cll_2021_10_006 crossref_primary_10_3389_fimmu_2022_864775 crossref_primary_10_1128_JCM_00290_21 crossref_primary_10_3389_fimmu_2021_658519 crossref_primary_10_1038_s41392_021_00777_z crossref_primary_10_1007_s13205_021_03076_0 crossref_primary_10_1038_s41587_022_01347_6 crossref_primary_10_1063_5_0079054 crossref_primary_10_1080_22221751_2022_2058419 crossref_primary_10_1016_j_jinf_2021_01_023 crossref_primary_10_1136_bmjopen_2021_052130 crossref_primary_10_1007_s40120_023_00448_x crossref_primary_10_3390_vaccines11040849 crossref_primary_10_1098_rsif_2021_0781 crossref_primary_10_3390_vaccines9080886 crossref_primary_10_1136_bmjopen_2021_051045 crossref_primary_10_1172_jci_insight_166711 crossref_primary_10_3389_fmed_2022_994160 crossref_primary_10_1016_j_jaci_2021_09_008 crossref_primary_10_1002_cti2_1319 crossref_primary_10_1038_s41586_022_04690_5 crossref_primary_10_1371_journal_pcbi_1010465 crossref_primary_10_1016_j_isci_2022_103743 crossref_primary_10_1093_infdis_jiab295 crossref_primary_10_1093_omcr_omab124 crossref_primary_10_30802_AALAS_CM_21_000011 crossref_primary_10_3390_vaccines10040510 crossref_primary_10_1002_ccr3_5400 crossref_primary_10_3390_idr16060088 crossref_primary_10_17816_MAJ624867 crossref_primary_10_1016_j_cll_2021_10_002 crossref_primary_10_1038_s41591_021_01230_y crossref_primary_10_1016_j_cell_2021_03_036 crossref_primary_10_1093_intimm_dxab008 crossref_primary_10_1007_s11095_022_03400_0 crossref_primary_10_1073_pnas_2019716118 crossref_primary_10_1093_gerona_glab206 crossref_primary_10_1002_cti2_1369 crossref_primary_10_1016_j_celrep_2021_109415 crossref_primary_10_1017_ice_2021_487 crossref_primary_10_1016_j_jcvp_2023_100158 crossref_primary_10_1016_j_jvacx_2022_100187 crossref_primary_10_1111_tri_13840 crossref_primary_10_3390_v13050917 crossref_primary_10_1155_2024_9970311 crossref_primary_10_1111_all_15066 crossref_primary_10_1093_oncolo_oyac196 crossref_primary_10_1038_s41467_021_27649_y crossref_primary_10_1016_j_jvacx_2022_100175 crossref_primary_10_1080_10408363_2023_2254390 crossref_primary_10_1093_cid_ciab345 crossref_primary_10_3390_vaccines10020154 crossref_primary_10_1016_j_lanepe_2021_100185 crossref_primary_10_3390_life11020144 crossref_primary_10_15789_1563_0625_FOH_2452 crossref_primary_10_1002_ctm2_342 crossref_primary_10_1016_S2665_9913_21_00114_4 crossref_primary_10_1093_ofid_ofab468 crossref_primary_10_1007_s15010_021_01703_9 crossref_primary_10_1371_journal_pone_0288557 crossref_primary_10_3390_v14030617 crossref_primary_10_1016_j_cmi_2021_05_041 crossref_primary_10_1016_j_cytogfr_2021_02_002 crossref_primary_10_15789_2220_7619_MIM_2009 crossref_primary_10_1111_sji_13088 crossref_primary_10_1016_j_pep_2021_105889 crossref_primary_10_1002_rmv_2272 crossref_primary_10_3390_vaccines12040377 crossref_primary_10_1016_j_ijid_2021_04_067 crossref_primary_10_1093_ejcts_ezac145 crossref_primary_10_3390_microorganisms11081985 crossref_primary_10_1007_s12072_022_10332_9 crossref_primary_10_1186_s12866_022_02450_z crossref_primary_10_1001_jamainternmed_2021_0366 crossref_primary_10_3389_fimmu_2021_708523 crossref_primary_10_1038_s41598_022_18302_9 crossref_primary_10_1002_eji_202149619 crossref_primary_10_1021_acs_analchem_1c00515 crossref_primary_10_3390_life10120320 crossref_primary_10_1007_s00391_021_01922_7 crossref_primary_10_1080_08830185_2021_1883600 crossref_primary_10_1007_s00216_022_03966_z crossref_primary_10_7759_cureus_24585 crossref_primary_10_1002_ana_26251 crossref_primary_10_1016_j_clinbiochem_2021_12_009 crossref_primary_10_1371_journal_pone_0271074 crossref_primary_10_1126_sciimmunol_abf7550 crossref_primary_10_3390_ijerph18063188 crossref_primary_10_4049_jimmunol_2100195 crossref_primary_10_1016_j_ajog_2021_03_028 crossref_primary_10_1016_j_jhin_2021_04_021 crossref_primary_10_3389_fimmu_2020_610688 crossref_primary_10_1016_j_envres_2021_111097 crossref_primary_10_1093_hropen_hoab028 crossref_primary_10_3389_fimmu_2021_739037 crossref_primary_10_1172_jci_insight_150449 crossref_primary_10_1038_s41392_024_02043_4 crossref_primary_10_1371_journal_ppat_1011298 crossref_primary_10_1021_acsami_2c06599 crossref_primary_10_1128_Spectrum_00830_21 crossref_primary_10_1128_Spectrum_00886_21 crossref_primary_10_1128_JCM_01231_21 crossref_primary_10_3390_s21206785 crossref_primary_10_1016_j_clim_2021_108871 crossref_primary_10_1016_j_puhe_2021_08_012 crossref_primary_10_1002_jmv_27231 crossref_primary_10_1007_s15010_021_01705_7 crossref_primary_10_1128_Spectrum_00247_21 crossref_primary_10_3390_vaccines10060858 crossref_primary_10_3390_vaccines9070685 crossref_primary_10_1021_acsnano_2c02794 crossref_primary_10_1186_s12916_021_02032_2 crossref_primary_10_3390_vaccines10020191 crossref_primary_10_3389_fphar_2021_778219 crossref_primary_10_1001_jamanetworkopen_2021_16572 crossref_primary_10_1093_infdis_jiaa803 crossref_primary_10_1016_j_vaccine_2022_07_040 crossref_primary_10_3389_fimmu_2021_737083 crossref_primary_10_1016_j_jim_2021_113160 crossref_primary_10_3390_vaccines9070697 crossref_primary_10_1038_s41392_021_00796_w crossref_primary_10_1111_tbed_14417 crossref_primary_10_3390_vaccines11121810 crossref_primary_10_1128_spectrum_00396_22 crossref_primary_10_1016_j_celrep_2021_109017 crossref_primary_10_1111_trf_16555 crossref_primary_10_3390_idr15010003 crossref_primary_10_3390_microorganisms9040733 crossref_primary_10_2478_amb_2024_0005 crossref_primary_10_2139_ssrn_3929650 crossref_primary_10_1016_j_clinbiochem_2023_03_003 crossref_primary_10_1016_j_heliyon_2021_e08140 crossref_primary_10_1371_journal_pone_0273694 crossref_primary_10_1136_bmjinnov_2021_000677 crossref_primary_10_1172_jci_insight_157031 crossref_primary_10_1093_ckj_sfab248 crossref_primary_10_3390_pathogens12070862 crossref_primary_10_1002_iid3_1154 crossref_primary_10_2147_IJGM_S337604 crossref_primary_10_1080_23744235_2021_1893378 crossref_primary_10_2139_ssrn_3929409 crossref_primary_10_1080_01913123_2022_2035475 crossref_primary_10_14348_molcells_2021_0075 crossref_primary_10_1001_jamanetworkopen_2021_24331 crossref_primary_10_1016_j_epidem_2021_100490 crossref_primary_10_1038_s41467_021_26774_y crossref_primary_10_3390_medicina57101077 crossref_primary_10_1126_scitranslmed_abd1525 crossref_primary_10_3389_fimmu_2022_1095129 crossref_primary_10_1017_S0950268822000747 crossref_primary_10_1097_TP_0000000000004105 crossref_primary_10_1111_imr_13091 crossref_primary_10_1016_j_cell_2021_01_007 crossref_primary_10_3389_fimmu_2022_856033 crossref_primary_10_3390_vaccines10020312 crossref_primary_10_1007_s00508_021_01963_3 crossref_primary_10_1080_21645515_2021_2002639 crossref_primary_10_3389_fimmu_2020_571481 crossref_primary_10_1136_bmjopen_2021_056370 crossref_primary_10_1371_journal_pone_0266923 crossref_primary_10_1128_mbio_03523_22 crossref_primary_10_1038_s41598_021_84913_3 crossref_primary_10_3390_jcm11216272 crossref_primary_10_1111_jam_15699 crossref_primary_10_3390_diseases12010029 crossref_primary_10_1038_s41591_021_01337_2 crossref_primary_10_1007_s11033_021_07020_6 crossref_primary_10_1111_all_15007 crossref_primary_10_1016_j_pathol_2021_05_093 crossref_primary_10_3390_v13071364 crossref_primary_10_1016_j_celrep_2022_110318 crossref_primary_10_1038_s41598_021_00844_z crossref_primary_10_3201_eid2704_204554 crossref_primary_10_3389_fimmu_2021_708184 crossref_primary_10_1111_imr_13089 crossref_primary_10_1038_s41467_021_22811_y crossref_primary_10_1038_s41392_021_00759_1 crossref_primary_10_1111_imr_13084 crossref_primary_10_1111_imr_13086 crossref_primary_10_1016_j_jtbi_2021_110973 crossref_primary_10_1038_s41467_021_21444_5 crossref_primary_10_1038_s41564_021_01051_2 crossref_primary_10_3390_vaccines10091532 crossref_primary_10_1016_j_jvacx_2022_100148 crossref_primary_10_1016_j_cell_2021_02_037 crossref_primary_10_3390_biomedicines10040781 crossref_primary_10_3390_v14112541 crossref_primary_10_1016_j_eclinm_2022_101526 crossref_primary_10_3390_ani11030667 crossref_primary_10_1016_S2213_2600_21_00158_2 crossref_primary_10_3390_v13112313 crossref_primary_10_1016_j_isci_2021_102937 crossref_primary_10_1016_S2213_2600_22_00100_X crossref_primary_10_1186_s12969_022_00724_4 crossref_primary_10_1136_archdischild_2020_321272 crossref_primary_10_3390_cells11010067 crossref_primary_10_1038_s41586_021_04060_7 crossref_primary_10_51620_0869_2084_2022_67_4_227_233 crossref_primary_10_1016_S0140_6736_21_00502_X crossref_primary_10_3390_antib13030072 crossref_primary_10_3389_fimmu_2022_817905 crossref_primary_10_1080_26895293_2021_1977186 crossref_primary_10_1002_jmv_27866 crossref_primary_10_1136_jech_2023_220569 crossref_primary_10_1038_s41423_023_01095_w crossref_primary_10_22141_2312_413X_9_1_2021_228825 crossref_primary_10_4049_immunohorizons_2200044 crossref_primary_10_1038_s43856_023_00352_3 crossref_primary_10_3389_fmicb_2022_1002748 crossref_primary_10_22141_2312_413X_9_1_2021_228823 crossref_primary_10_1172_jci_insight_157699 crossref_primary_10_37349_ei_2021_00014 crossref_primary_10_1080_19420862_2022_2031483 crossref_primary_10_1093_cid_ciaa1936 crossref_primary_10_3389_fmicb_2021_661187 crossref_primary_10_1007_s43615_021_00051_y crossref_primary_10_1002_ange_202015362 crossref_primary_10_1111_vox_13162 crossref_primary_10_1126_scitranslmed_abg0485 crossref_primary_10_1016_j_celrep_2022_110515 crossref_primary_10_1371_journal_pone_0258041 |
| Cites_doi | 10.1038/s41467-020-18450-4 10.1126/science.abc4776 10.1128/CVI.00131-10 10.1126/science.abb2507 10.1073/pnas.2009799117 10.1016/S2666-5247(20)30120-8 10.1126/science.abc5343 10.1002/1096-9071(200101)63:1<1::AID-JMV1000>3.0.CO;2-U 10.1038/s41586-020-2381-y 10.1038/s41591-020-0913-5 10.1080/22221751.2020.1791738 10.1101/2020.06.28.20142190 10.1038/s41591-020-1088-9 10.1038/s41591-020-0897-1 10.1002/cpmc.108 10.1126/science.abc1227 10.1002/cpmc.100 10.1126/science.abc6284 10.1111/irv.12706 10.1038/s41591-020-0965-6 10.1016/j.immuni.2020.03.007 10.1038/s41564-020-0688-y |
| ContentType | Journal Article |
| Copyright | Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works 2020 American Association for the Advancement of Science |
| Copyright_xml | – notice: Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. – notice: Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works – notice: Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works 2020 American Association for the Advancement of Science |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QF 7QG 7QL 7QP 7QQ 7QR 7SC 7SE 7SN 7SP 7SR 7SS 7T7 7TA 7TB 7TK 7TM 7U5 7U9 8BQ 8FD C1K F28 FR3 H8D H8G H94 JG9 JQ2 K9. KR7 L7M L~C L~D M7N P64 RC3 7X8 5PM |
| DOI | 10.1126/science.abd7728 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Aluminium Industry Abstracts Animal Behavior Abstracts Bacteriology Abstracts (Microbiology B) Calcium & Calcified Tissue Abstracts Ceramic Abstracts Chemoreception Abstracts Computer and Information Systems Abstracts Corrosion Abstracts Ecology Abstracts Electronics & Communications Abstracts Engineered Materials Abstracts Entomology Abstracts (Full archive) Industrial and Applied Microbiology Abstracts (Microbiology A) Materials Business File Mechanical & Transportation Engineering Abstracts Neurosciences Abstracts Nucleic Acids Abstracts Solid State and Superconductivity Abstracts Virology and AIDS Abstracts METADEX Technology Research Database Environmental Sciences and Pollution Management ANTE: Abstracts in New Technology & Engineering Engineering Research Database Aerospace Database Copper Technical Reference Library AIDS and Cancer Research Abstracts Materials Research Database ProQuest Computer Science Collection ProQuest Health & Medical Complete (Alumni) Civil Engineering Abstracts Advanced Technologies Database with Aerospace Computer and Information Systems Abstracts Academic Computer and Information Systems Abstracts Professional Algology Mycology and Protozoology Abstracts (Microbiology C) Biotechnology and BioEngineering Abstracts Genetics Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Materials Research Database Technology Research Database Computer and Information Systems Abstracts – Academic Mechanical & Transportation Engineering Abstracts Nucleic Acids Abstracts ProQuest Computer Science Collection Computer and Information Systems Abstracts ProQuest Health & Medical Complete (Alumni) Materials Business File Environmental Sciences and Pollution Management Aerospace Database Copper Technical Reference Library Engineered Materials Abstracts Genetics Abstracts Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) AIDS and Cancer Research Abstracts Chemoreception Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) Advanced Technologies Database with Aerospace ANTE: Abstracts in New Technology & Engineering Civil Engineering Abstracts Aluminium Industry Abstracts Virology and AIDS Abstracts Electronics & Communications Abstracts Ceramic Abstracts Ecology Abstracts Neurosciences Abstracts METADEX Biotechnology and BioEngineering Abstracts Computer and Information Systems Abstracts Professional Entomology Abstracts Animal Behavior Abstracts Solid State and Superconductivity Abstracts Engineering Research Database Calcium & Calcified Tissue Abstracts Corrosion Abstracts MEDLINE - Academic |
| DatabaseTitleList | Materials Research Database MEDLINE - Academic CrossRef MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Sciences (General) Biology |
| EISSN | 1095-9203 |
| EndPage | 1230 |
| ExternalDocumentID | PMC7810037 33115920 10_1126_science_abd7728 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GrantInformation_xml | – fundername: NIAID NIH HHS grantid: HHSN272201400008C – fundername: NIAID NIH HHS grantid: 75N93019C00051 – fundername: NCI NIH HHS grantid: U54 CA260560 – fundername: NCI NIH HHS grantid: 75N91019D00024 – fundername: ; grantid: HHSN272201400008C – fundername: ; – fundername: ; grantid: #2020-215611 – fundername: ; grantid: 75N93019C00051 |
| GroupedDBID | --- --Z -DZ -ET -~X .-4 ..I .55 .DC 08G 0R~ 0WA 123 18M 2FS 2KS 2WC 2XV 34G 36B 39C 3R3 53G 5RE 66. 6OB 6TJ 7X2 7~K 85S 8F7 AABCJ AACGO AAIKC AAMNW AANCE AAWTO AAYXX ABCQX ABDBF ABDEX ABDQB ABEFU ABIVO ABJNI ABOCM ABPLY ABPPZ ABQIJ ABTLG ABWJO ABZEH ACBEA ACBEC ACGFO ACGFS ACGOD ACIWK ACMJI ACNCT ACPRK ACQOY ACUHS ADDRP ADUKH ADXHL AEGBM AENEX AETEA AFBNE AFFNX AFHKK AFQFN AFRAH AGFXO AGNAY AGSOS AHMBA AIDAL AIDUJ AJGZS ALIPV ALMA_UNASSIGNED_HOLDINGS ALSLI ASPBG AVWKF BKF BLC C45 CITATION CS3 DB2 DU5 EBS EMOBN F5P FA8 FEDTE HZ~ I.T IAO IEA IGS IH2 IHR INH INR IOF IOV IPO IPY ISE JCF JLS JSG JST K-O KCC L7B LSO LU7 M0P MQT MVM N9A NEJ NHB O9- OCB OFXIZ OGEVE OMK OVD P-O P2P PQQKQ PZZ RHI RXW SC5 SJN TAE TEORI TN5 TWZ UBW UCV UHB UKR UMD UNMZH UQL USG VVN WH7 WI4 X7M XJF XZL Y6R YK4 YKV YNT YOJ YR2 YR5 YRY YSQ YV5 YWH YYP YZZ ZCA ZE2 ~02 ~G0 ~KM ~ZZ 0B8 AEUPB CGR CUY CVF ECM EIF ESX GX1 IGG NPM OK1 PKN RHF UIG VQA YCJ YIF YIN 7QF 7QG 7QL 7QP 7QQ 7QR 7SC 7SE 7SN 7SP 7SR 7SS 7T7 7TA 7TB 7TK 7TM 7U5 7U9 8BQ 8FD C1K F28 FR3 H8D H8G H94 JG9 JQ2 K9. KR7 L7M L~C L~D M7N P64 RC3 7X8 5PM |
| ID | FETCH-LOGICAL-c515t-f252b7e765f4ccf4b09aac3ff18635d4d79669b80c2f8b07e53db122d5809e883 |
| ISSN | 0036-8075 1095-9203 |
| IngestDate | Thu Aug 21 18:34:13 EDT 2025 Fri Jul 11 05:53:10 EDT 2025 Fri Jul 25 10:41:16 EDT 2025 Wed Feb 19 02:27:54 EST 2025 Thu Apr 24 23:04:52 EDT 2025 Tue Jul 01 01:35:20 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 6521 |
| Language | English |
| License | https://creativecommons.org/licenses/by/4.0 Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. This is an open-access article distributed under the terms of the Creative Commons Attribution license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c515t-f252b7e765f4ccf4b09aac3ff18635d4d79669b80c2f8b07e53db122d5809e883 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ORCID | 0000-0001-6792-7650 0000-0003-4121-776X 0000-0003-0095-515X 0000-0003-0858-5624 0000-0001-6217-272X 0000-0001-5063-7016 0000-0003-2628-9474 0000-0002-8029-8227 0000-0002-7450-6624 0000-0002-6416-5096 0000-0003-1948-3834 0000-0002-6754-7209 0000-0001-8162-0284 |
| OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC7810037 |
| PMID | 33115920 |
| PQID | 2467610390 |
| PQPubID | 1256 |
| PageCount | 4 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_7810037 proquest_miscellaneous_2455840811 proquest_journals_2467610390 pubmed_primary_33115920 crossref_primary_10_1126_science_abd7728 crossref_citationtrail_10_1126_science_abd7728 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2020-12-04 |
| PublicationDateYYYYMMDD | 2020-12-04 |
| PublicationDate_xml | – month: 12 year: 2020 text: 2020-12-04 day: 04 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States – name: Washington |
| PublicationTitle | Science (American Association for the Advancement of Science) |
| PublicationTitleAlternate | Science |
| PublicationYear | 2020 |
| Publisher | The American Association for the Advancement of Science American Association for the Advancement of Science |
| Publisher_xml | – name: The American Association for the Advancement of Science – name: American Association for the Advancement of Science |
| References | e_1_3_2_9_2 e_1_3_2_15_2 e_1_3_2_8_2 e_1_3_2_16_2 e_1_3_2_7_2 e_1_3_2_17_2 e_1_3_2_6_2 e_1_3_2_18_2 e_1_3_2_19_2 e_1_3_2_20_2 e_1_3_2_10_2 e_1_3_2_21_2 e_1_3_2_5_2 e_1_3_2_11_2 e_1_3_2_22_2 e_1_3_2_4_2 e_1_3_2_12_2 e_1_3_2_23_2 e_1_3_2_3_2 e_1_3_2_13_2 e_1_3_2_2_2 e_1_3_2_14_2 33637679 - Signal Transduct Target Ther. 2021 Feb 26;6(1):95 33790222 - Signal Transduct Target Ther. 2021 Mar 31;6(1):137 |
| References_xml | – ident: e_1_3_2_18_2 doi: 10.1038/s41467-020-18450-4 – ident: e_1_3_2_20_2 doi: 10.1126/science.abc4776 – ident: e_1_3_2_16_2 doi: 10.1128/CVI.00131-10 – ident: e_1_3_2_5_2 doi: 10.1126/science.abb2507 – ident: e_1_3_2_22_2 doi: 10.1073/pnas.2009799117 – ident: e_1_3_2_9_2 doi: 10.1016/S2666-5247(20)30120-8 – ident: e_1_3_2_19_2 doi: 10.1126/science.abc5343 – ident: e_1_3_2_17_2 doi: 10.1002/1096-9071(200101)63:1<1::AID-JMV1000>3.0.CO;2-U – ident: e_1_3_2_21_2 doi: 10.1038/s41586-020-2381-y – ident: e_1_3_2_8_2 doi: 10.1038/s41591-020-0913-5 – ident: e_1_3_2_2_2 doi: 10.1080/22221751.2020.1791738 – ident: e_1_3_2_10_2 doi: 10.1101/2020.06.28.20142190 – ident: e_1_3_2_12_2 doi: 10.1038/s41591-020-1088-9 – ident: e_1_3_2_3_2 doi: 10.1038/s41591-020-0897-1 – ident: e_1_3_2_13_2 doi: 10.1002/cpmc.108 – ident: e_1_3_2_4_2 doi: 10.1126/science.abc1227 – ident: e_1_3_2_11_2 doi: 10.1002/cpmc.100 – ident: e_1_3_2_23_2 doi: 10.1126/science.abc6284 – ident: e_1_3_2_15_2 doi: 10.1111/irv.12706 – ident: e_1_3_2_14_2 doi: 10.1038/s41591-020-0965-6 – ident: e_1_3_2_7_2 doi: 10.1016/j.immuni.2020.03.007 – ident: e_1_3_2_6_2 doi: 10.1038/s41564-020-0688-y – reference: 33790222 - Signal Transduct Target Ther. 2021 Mar 31;6(1):137 – reference: 33637679 - Signal Transduct Target Ther. 2021 Feb 26;6(1):95 |
| SSID | ssj0009593 |
| Score | 2.728661 |
| Snippet | As the number of daily COVID-19 cases continues to mount worldwide, the nature of the humoral immune response to severe acute respiratory syndrome coronavirus... Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global pandemic with millions infected and more than 1 million fatalities. Questions... SARS-CoV-2 antibodies persistAs the number of daily COVID-19 cases continues to mount worldwide, the nature of the humoral immune response to severe acute... |
| SourceID | pubmedcentral proquest pubmed crossref |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | 1227 |
| SubjectTerms | Antibodies Antibodies, Neutralizing - blood Antibodies, Neutralizing - immunology Antibodies, Viral - blood Antibodies, Viral - immunology Antibody response Coronaviridae Coronaviruses COVID-19 COVID-19 - blood COVID-19 - immunology Enzyme-Linked Immunosorbent Assay Feedback (Response) Humans IgG antibody Immune response Immune response (humoral) Immune system Immunoglobulin G Immunoglobulin G - blood Immunoglobulin G - immunology Infections Longevity Microbio Neutralization Neutralization Tests Neutralizing Pandemics Proteins Respiratory diseases Robustness SARS-CoV-2 - immunology Severe acute respiratory syndrome coronavirus 2 Spike protein Viral diseases Viruses |
| Title | Robust neutralizing antibodies to SARS-CoV-2 infection persist for months |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/33115920 https://www.proquest.com/docview/2467610390 https://www.proquest.com/docview/2455840811 https://pubmed.ncbi.nlm.nih.gov/PMC7810037 |
| Volume | 370 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEBbbhEIvpUlfbtKiQg8pxYtXfslH57GkJU0h2W33ZiRbJlsWO6ztQ_LrO7Jk2ZukkPZijCVbRt9oNCN9M0LoU-ST3EthAIZuGsmlG2azKM9tmrkBD6jw3TZPwffz4HTufVv4i9GoGUaX1Hyc3j4YV_I_qMIzwFVGyf4Dsuaj8ADuAV-4AsJwfRTGFyVvqvpLIZp2veJWBRzWS15KbqA0Ky_ji0v7qPxpE0O7kqzxdQXotgxD-Nf6qhqaqN1oB9PTbOcMQDS8xFixBzoygX5tsLLwi_027LG4WBr9H0vGbKv7p_DFfl6YLtfXKugmK1d5aaqvar1Keww-N9MMR71QQRTpwxvoVkceC0kcpc_EA8-0QnbVUSJa8gJfhVBrDTshKpfAfdU_OKxSjBnPwG-g_SzX7eyf_0im87OzZHaymD1B2wRqgXrcjg-PD6d3szWbv9M5oQbRVl0Dm-bMPR_lLtV2YLvMXqDn2unAsZKgHTQSxS56qo4hvdlFOxq7Ch_oLOSfX6KvSrjwULhwL1y4LnEvXNgIF9bChUFMsBKuV2g-PZkdndr63A07Beu2tnPiEx6KMPBhGKe5x52IsdTN8wkF8zTzshB85IhTJyU55U4IAzrjgEvmUycSlLqv0VZRFuItwlDgpgJ8EFdkMDsI6DSwx92AUhqxjHELjbvuS1KdlF6ejbJKWueUBInu70T3t4UOzAvXKh_L36vud3gketBWCQHDIJD0B8dCH00xqFS5T8YKUTayjg9mOdjKEwu9UfCZtlyZnQpEwkLhBrCmgkzXvllSLK_atO0hnchsT-8e0e4eetaPoH20Va8b8R6M35p_0KL6B8tmtKc |
| linkProvider | EBSCOhost |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Robust+neutralizing+antibodies+to+SARS-CoV-2+infection+persist+for+months&rft.jtitle=Science+%28American+Association+for+the+Advancement+of+Science%29&rft.au=Wajnberg%2C+Ania&rft.au=Amanat%2C+Fatima&rft.au=Firpo%2C+Adolfo&rft.au=Altman%2C+Deena+R&rft.date=2020-12-04&rft.issn=1095-9203&rft.eissn=1095-9203&rft.volume=370&rft.issue=6521&rft.spage=1227&rft_id=info:doi/10.1126%2Fscience.abd7728&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0036-8075&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0036-8075&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0036-8075&client=summon |